Macom Technology Solutions Holdings, Inc.NASDAQ: MTSI

MACOM Reports Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results

· Issued by Macom Technology Solutions Holdings, Inc. via GlobeNewswire

LOWELL, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced its financial results for its fiscal fourth quarter and fiscal year ended October 3, 2025.

Fourth Quarter Fiscal Year 2025 GAAP Results

  • Revenue was $261.2 million, an increase of 30.1%, compared to $200.7 million in the previous year fiscal fourth quarter and an increase of 3.6% compared to $252.1 million in the prior fiscal quarter;

  • Gross margin was 54.5%, compared to 54.7% in the previous year fiscal fourth quarter and 55.3% in the prior fiscal quarter;

  • Income from operations was $39.6 million, or 15.2% of revenue, compared to income from operations of $27.5 million, or 13.7% of revenue, in the previous year fiscal fourth quarter and income from operations of $37.7 million, or 14.9% of revenue, in the prior fiscal quarter; and

  • Net income was $45.1 million, or $0.59 per diluted share, compared to net income of $29.4 million, or $0.39 per diluted share, in the previous year fiscal fourth quarter and net income of $36.5 million, or $0.48 per diluted share, in the prior fiscal quarter. The fiscal fourth quarter of 2025 included a $10.1 million gain on acquired assets associated with the transfer of a fabrication facility.

Fourth Quarter Fiscal Year 2025 Adjusted Non-GAAP Results

  • Adjusted gross margin was 57.1%, compared to 58.1% in the previous year fiscal fourth quarter and 57.6% in the prior fiscal quarter;

  • Adjusted income from operations was $67.0 million, or 25.6% of revenue, compared to adjusted income from operations of $50.7 million, or 25.2% of revenue, in the previous year fiscal fourth quarter and adjusted income from operations of $63.5 million, or 25.2% of revenue, in the prior fiscal quarter; and

  • Adjusted net income was $71.4 million, or $0.94 per diluted share, compared to adjusted net income of $54.2 million, or $0.73 per diluted share, in the previous year fiscal fourth quarter and adjusted net income of $68.2 million, or $0.90 per diluted share, in the prior fiscal quarter.

Fiscal Year 2025 GAAP Results

  • Revenue was $967.3 million, an increase of 32.6%, compared to $729.6 million in fiscal year 2024;

  • Gross margin was 54.7%, compared to 54.0% in fiscal year 2024;

  • Income from operations was $129.7 million, compared to $73.7 million in fiscal year 2024; and

  • Net loss was $54.2 million, or $0.73 loss per diluted share, which includes a one-time, primarily non-cash, charge of $193.1 million loss on extinguishment of debt related to the refinancing of a portion of the Company’s convertible senior notes due 2026, compared to a net income of $76.9 million, or $1.04 income per diluted share in fiscal year 2024.

Fiscal Year 2025 Adjusted Non-GAAP Results

  • Adjusted gross margin was 57.4%, compared to 57.9% in fiscal year 2024;

  • Adjusted income from operations was $245.7 million, or 25.4% of revenue, compared to $175.0 million, or 24.0% of revenue, in fiscal year 2024; and

  • Adjusted net income was $263.4 million, or $3.47 per diluted share, compared to adjusted net income of $188.2 million, or $2.56 per diluted share in fiscal year 2024.

Management Commentary

“We built upon our strong foundation in fiscal year 2025, and we look forward to starting fiscal 2026,” said Stephen G. Daly, President and Chief Executive Officer, MACOM.

Business Outlook

For the fiscal first quarter ending January 2, 2026, MACOM expects revenue to be in the range of $265 million to $273 million. Adjusted gross margin is expected to be between 56.5% and 58.5%, and adjusted earnings per diluted share is expected to be between $0.98 and $1.02 utilizing an anticipated non-GAAP income tax rate of 3% and 76.6 million fully diluted shares outstanding.

Conference Call

MACOM will host a conference call on Thursday, November 6, 2025, at 8:30 a.m. Eastern Time to discuss its fiscal fourth quarter and fiscal year 2025 financial results and business outlook. Investors and analysts may visit MACOM's Investor Relations website at https://ir.macom.com/events-webcasts to register for a user-specific access code for the live call or to access the live webcast. A replay of the call will be available within 24 hours and remain accessible by all interested parties for approximately 90 days.

About MACOM

MACOM designs and manufactures high-performance semiconductor products for the Industrial and Defense, Data Center and Telecommunications industries. MACOM services over 6,000 customers annually with a broad product portfolio that incorporates RF, Microwave, Analog and Mixed Signal and Optical semiconductor technologies. MACOM has achieved certification to the IATF16949 automotive standard, the AS9100D aerospace standard, the ISO9001 international quality standard and the ISO14001 environmental management standard. MACOM operates facilities across the United States, Europe, Asia and is headquartered in Lowell, Massachusetts.

Special Note Regarding Forward-Looking Statements

This press release and the associated earnings call contains forward-looking statements. These forward-looking statements include, among others, statements about MACOM’s strategic plans, priorities and long-term growth drivers, our ability to execute our long-term strategy, strengthen our position and drive market share gains and growth, our ability to develop new products, achieve market acceptance of those products and better address certain markets, expand our capabilities and extend our product offerings, including through the acquisitions of ENGIN-IC, Inc., Linearizer Communications Group and the radio frequency (RF) business of Wolfspeed, Inc., including our ability to effectively integrate and execute at the Research Triangle Park, North Carolina RF business fabrication facility, and through the establishment and growth of our European Semiconductor Center and in connection with the license agreement with HRL Laboratories and potential collaboration and sales opportunities with private and public sector partners resulting therefrom, and the teams’ capabilities and technologies and expansion thereof and any potential financial benefits derived by and financial impact to MACOM therefrom, strength and competitiveness of new product introductions and technology portfolio expansion, including the anticipated rate of new product introductions, anticipated demand for our products, MACOM’s profitability, revenue targets, gross margins improvements, prospects and growth opportunities in our three primary markets, the potential impact to our business of an economic downturn or recession, anticipated financial and business performance improvements, MACOM’s strategic investment and other plans, including negotiation and finalization of a definitive agreement with, and receipt of, funding from the Federal and State governments, the estimated financial results for our 2026 fiscal first quarter and the stated business outlook and future results of operations.

These forward-looking statements reflect MACOM’s current views about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause those events or our actual activities or results to differ materially from those indicated by the forward-looking statements, including our ability to develop new products and achieve market acceptance of those products; component shortages or other disruptions in our supply chain, including as a result of geopolitical unrest or otherwise; inflationary pressures; any failure to accurately anticipate demand for our products and effectively manage our inventory; our dependence on a limited number of customers; risks related to any weakening of global economic conditions, including as a result of the evolving impacts from tariffs, sanctions or other trade tensions (including implementation of new tariffs, export bans or retaliatory trade measures); the impact of government shutdowns and the July 4, 2025 Bill on our business; our ability to compete effectively; and those other factors described in “Risk Factors” in MACOM’s filings with the Securities and Exchange Commission (“SEC”), including its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q and other filings with the SEC. These forward-looking statements speak only as of the date of this press release, and MACOM undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Discussion Regarding the Use of Historical and Forward-Looking Non-GAAP Financial Measures

In addition to United States Generally Accepted Accounting Principles (“GAAP”) reporting, MACOM provides investors with financial measures that have not been calculated in accordance with GAAP, such as: non-GAAP gross profit and gross margin, non-GAAP operating expenses, non-GAAP income from operations and operating margin, non-GAAP EBITDA, non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP diluted shares, non-GAAP income tax rate and non-GAAP interest income. In this release or elsewhere, we may alternatively refer to such non-GAAP measures as “adjusted” measures. This non-GAAP information excludes the effect, where applicable, of intangible amortization expense, share-based compensation expense, non-cash interest, net, acquisition and integration related costs, loss on debt extinguishment, gain on acquired assets and the tax effect of each non-GAAP adjustment.

Management believes these excluded items are not reflective of our underlying performance and uses these non-GAAP financial measures to: evaluate our ongoing operating performance and compare it against prior periods, make operating decisions, forecast future periods, evaluate potential acquisitions, compare our operating performance against peer companies and assess certain compensation programs. We believe this non-GAAP financial information provides additional insight into our ongoing performance and have therefore chosen to provide this information to investors to help them evaluate the results of our ongoing operations and enable more meaningful period-to-period comparisons. These non-GAAP measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.

A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. We have not provided a reconciliation with respect to any forward-looking non-GAAP financial data presented because we do not have and cannot reliably estimate certain key inputs required to calculate the most comparable GAAP financial data, such as future acquisition costs, the possibility and impact of any litigation costs, changes in our GAAP effective tax rate and impairment charges. We believe these unknown inputs are likely to have a significant impact on any estimate of the comparable GAAP financial data.

Investors are cautioned against placing undue reliance on non-GAAP financial measures and are urged to review and consider carefully the adjustments made by management to the most directly comparable GAAP financial measures. Non-GAAP financial measures may have limited value as analytical tools because they may exclude certain expenses that some investors consider important in evaluating our operating performance or ongoing business performance. Further, non-GAAP financial measures may have limited value for purposes of drawing comparisons between companies because different companies may calculate similarly titled non-GAAP financial measures in different ways because non-GAAP measures are not based on any comprehensive set of accounting rules or principles.

Additional information and management’s assessment regarding why certain items are excluded from our non-GAAP measures are summarized below:

Amortization Expense – is related to acquired intangible assets which are based upon valuation methodologies and are generally amortized over the expected life of the intangible asset at the time of acquisition, which may result in amortization amounts that vary over time. This non-cash expense is not considered by management in making operating decisions.

Share-Based Compensation Expense – includes share-based compensation expense for awards that are equity and liability classified on our balance sheet and the related employer tax expense at vesting. Share-based compensation expense is partially outside of our control due to factors such as stock price volatility and interest rates, which may be unrelated to our operating performance during the period in which the expense is incurred. It is an expense based upon valuation methodologies and assumptions that vary over time, and the amount of the expense can vary significantly between companies. Share-based compensation expense amounts are not considered by management in making operating decisions.

Non-cash Interest, Net – includes amounts associated with the amortization of certain fees associated with the establishment or amendment of our convertible notes that are being amortized over the life of the agreements. We believe these amounts are non-cash in nature, are not correlated to future business operations and do not reflect our ongoing operations.

Acquisition and Integration Related Costs – includes items such as professional fees, employee severance and other costs incurred in connection with acquisitions and integration specific activities which are not expected to have a continuing contribution to operations and the amortization of the fair market step-up value of acquired inventory and fixed assets. We believe the exclusion of these items is useful in providing management a basis to evaluate ongoing operating activities and strategic decision making.

Loss on Debt Extinguishment – includes loss on exchange of our convertible notes. This fiscal first quarter 2025 loss is primarily non-cash and we do not believe this amount is reflective of our ongoing operations.

Gain on acquired assets – includes the gain on transfer of assets, primarily inventory, associated with the Research Triangle Park, North Carolina RF business fabrication facility that we assumed in the fiscal fourth quarter of 2025 related to the RF business acquisition completed in fiscal year 2024. We believe this gain is not correlated to future business operations and does not reflect our ongoing operations.

Tax Effect of Non-GAAP Adjustments – includes adjustments to arrive at an estimate of our non-GAAP income tax rate associated with our non-GAAP income over a period of time. We determine our non-GAAP income tax rate using applicable rates in taxing jurisdictions and assessing certain factors including our historical and forecast earnings by jurisdiction, discrete items, cash taxes paid in relation to our non-GAAP net income before income taxes and our ability to realize tax assets. We generally assess this non-GAAP income tax rate quarterly and have utilized 3% for fiscal years 2025 and 2024. Our historical effective income tax rate under GAAP has varied significantly from our non-GAAP income tax rate due primarily to income taxed in foreign jurisdictions at generally lower tax rates, research and development tax credits and acquisition expenses. We believe it is beneficial for management to review our non-GAAP income tax rate on a consistent basis over periods of time. Items such as those noted above may have a significant impact on our GAAP income tax expense and associated effective tax rate over time.

Adjusted EBITDA – is a calculation that adds depreciation expense to our adjusted income from operations. Management reviews and utilizes this measure for operational analysis purposes. We believe competitors and others in the financial industry also utilize this measure for analysis purposes.

Incremental Shares – is the number of potential shares of common stock issuable upon the exercise of stock options, restricted stock, restricted stock units and conversion of convertible debt which were not included in the calculation of our GAAP diluted shares. We believe competitors and others in the financial industry utilize this non-GAAP measure for analysis purposes.

Company Contact:
MACOM Technology Solutions Holdings, Inc.
Stephen Ferranti
Vice President, Corporate Development and Investor Relations
P: 978-656-2977
E: stephen.ferranti@macom.com

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited and in thousands, except per share data)

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Revenue

$

261,170

$

252,079

$

200,710

$

967,258

$

729,578

Cost of revenue

118,869

112,643

90,868

438,256

335,805

Gross profit

142,301

139,436

109,842

529,002

393,773

Operating expenses:

Research and development

62,880

63,380

49,592

244,466

182,158

Selling, general and administrative

39,826

38,396

32,716

154,884

137,949

Total operating expenses

102,706

101,776

82,308

399,350

320,107

Income from operations

39,595

37,660

27,534

129,652

73,666

Other income (expense):

Interest income

8,016

7,598

6,244

29,853

22,986

Interest expense

(1,793

)

(1,178

)

(1,274

)

(5,516

)

(5,136

)

Loss on extinguishment of debt

—

—

—

(193,098

)

—

Gain on acquired assets and other income, net

10,084

—

10

10,084

10

Total other income (expense)

16,307

6,420

4,980

(158,677

)

17,860

Income (loss) before income taxes

55,902

44,080

32,514

(29,025

)

91,526

Income tax expense

10,782

7,546

3,100

25,185

14,667

Net income (loss)

$

45,120

$

36,534

$

29,414

$

(54,210

)

$

76,859

Net income (loss) per share:

Income (loss) per share - Basic

$

0.61

$

0.49

$

0.41

$

(0.73

)

$

1.07

Income (loss) per share - Diluted

$

0.59

$

0.48

$

0.39

$

(0.73

)

$

1.04

Weighted average common shares:

Shares - Basic

74,473

74,427

72,192

73,986

71,959

Shares - Diluted

76,252

75,864

74,524

73,986

73,575

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited and in thousands)

October 3, 2025

September 27, 2024

ASSETS

Current assets:

Cash and cash equivalents

$

112,142

$

146,806

Short-term investments

673,833

435,082

Accounts receivable, net

148,646

105,700

Inventories

237,844

194,490

Prepaid and other current assets

32,623

21,000

Total current assets

1,205,088

903,078

Property and equipment, net

230,291

176,017

Goodwill and intangible assets, net

414,885

408,289

Deferred income taxes

207,999

212,495

Other long-term assets

45,097

55,761

Total assets

$

2,103,360

$

1,755,640

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Short-term debt

$

160,946

$

—

Accounts payable

67,588

43,202

Accrued liabilities

96,585

64,982

Total current liabilities

325,119

108,184

Finance lease obligations, less current portion

30,504

31,130

Financing obligation

37,014

9,006

Long-term debt obligations

339,630

448,281

Other long-term liabilities

43,998

32,696

Total liabilities

776,265

629,297

Stockholders’ equity

1,327,095

1,126,343

Total liabilities and stockholders’ equity

$

2,103,360

$

1,755,640

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited and in thousands)

Twelve Months Ended

October 3, 2025

September 27, 2024

CASH FLOWS FROM OPERATING ACTIVITIES:

Net (loss) income

$

(54,210

)

$

76,859

Depreciation and intangible asset amortization

63,295

67,249

Share-based compensation

79,362

45,644

Deferred income taxes

2,637

4,947

Loss on extinguishment of debt

193,098

—

Gain on acquired assets

(10,084

)

—

Other adjustments, net

(939

)

(1,029

)

Accounts receivable

(41,980

)

(16,805

)

Inventories

(26,562

)

(30,225

)

Accounts payable

22,210

18,230

Change in other operating assets and liabilities

8,541

(2,230

)

Net cash provided by operating activities

235,368

162,640

CASH FLOWS FROM INVESTING ACTIVITIES:

Acquisition of business, net

(12,684

)

(72,615

)

Sales, purchases and maturities of investments

(232,212

)

(81,752

)

Purchases of property and equipment

(42,551

)

(22,440

)

Purchase of property under financing arrangement

(28,750

)

—

Purchases of software licenses

(10,866

)

(3,188

)

Other investing

(1,200

)

(1,138

)

Net cash used in investing activities

(328,263

)

(181,133

)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from convertible notes

86,629

—

Proceeds from financing arrangement

28,750

—

Payments for fee on convertible note exchange and debt issuance costs

(23,166

)

—

Payments on finance leases and other

(1,268

)

(1,431

)

Proceeds from stock option exercises and employee stock purchases

10,289

6,586

Common stock withheld for taxes on employee equity awards

(43,135

)

(14,219

)

Net cash provided by (used in) financing activities

58,099

(9,064

)

Foreign currency effect on cash

132

411

NET CHANGE IN CASH AND CASH EQUIVALENTS

(34,664

)

(27,146

)

CASH AND CASH EQUIVALENTS — Beginning of period

146,806

173,952

CASH AND CASH EQUIVALENTS — End of period

$

112,142

$

146,806

Supplemental disclosure of certain non-cash activities

Issuance of common stock for convertible debt exchange

$

205,915

$

—

Issuance of common stock in connection with the acquisition of the RF business of Wolfspeed, Inc.

$

—

$

57,733

MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INC.
RECONCILIATIONS OF GAAP TO NON-GAAP RESULTS
(unaudited and in thousands, except per share data)

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Gross profit - GAAP

$

142,301

54.5

$

139,436

55.3

$

109,842

54.7

$

529,002

54.7

$

393,773

54.0

Amortization expense

4,309

1.6

3,349

1.3

4,305

2.1

14,333

1.5

14,790

2.0

Share-based compensation expense

2,198

0.8

2,058

0.8

1,703

0.8

9,519

1.0

6,754

0.9

Acquisition and integration related costs

330

0.1

355

0.1

744

0.4

2,435

0.3

7,319

1.0

Adjusted gross profit (Non-GAAP)

$

149,138

57.1

$

145,198

57.6

$

116,594

58.1

$

555,289

57.4

$

422,636

57.9

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Operating expenses - GAAP

$

102,706

39.3

$

101,776

40.4

$

82,308

41.0

$

399,350

41.3

$

320,107

43.9

Amortization expense

(1,620

)

(0.6

)

(1,618

)

(0.6

)

(4,351

)

(2.2

)

(8,032

)

(0.8

)

(17,602

)

(2.4

)

Share-based compensation expense

(15,890

)

(6.1

)

(17,510

)

(6.9

)

(10,800

)

(5.4

)

(76,620

)

(7.9

)

(43,437

)

(6.0

)

Acquisition and integration related costs

(3,048

)

(1.2

)

(966

)

(0.4

)

(1,221

)

(0.6

)

(5,141

)

(0.5

)

(11,465

)

(1.6

)

Adjusted operating expenses (Non-GAAP)

$

82,148

31.5

$

81,682

32.4

$

65,936

32.9

$

309,557

32.0

$

247,603

33.9

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Income from operations - GAAP

$

39,595

15.2

$

37,660

14.9

$

27,534

13.7

$

129,652

13.4

$

73,666

10.1

Amortization expense

5,929

2.3

4,967

2.0

8,656

4.3

22,365

2.3

32,392

4.4

Share-based compensation expense

18,088

6.9

19,568

7.8

12,503

6.2

86,139

8.9

50,191

6.9

Acquisition and integration related costs

3,378

1.3

1,321

0.5

1,965

1.0

7,576

0.8

18,784

2.6

Adjusted income from operations (Non-GAAP)

$

66,990

25.6

$

63,516

25.2

$

50,658

25.2

$

245,732

25.4

$

175,033

24.0

Depreciation expense

8,716

3.3

6,856

2.7

7,257

3.6

29,115

3.0

28,097

3.9

Adjusted EBITDA (Non-GAAP)

$

75,706

29.0

$

70,372

27.9

$

57,915

28.9

$

274,847

28.4

$

203,130

27.8

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Net income (loss) - GAAP

$

45,120

17.3

$

36,534

14.5

$

29,414

14.7

$

(54,210

)

(5.6

)

$

76,859

10.5

Amortization expense

5,929

2.3

4,967

2.0

8,656

4.3

22,365

2.3

32,392

4.4

Share-based compensation expense

18,088

6.9

19,568

7.8

12,502

6.2

86,139

8.9

50,191

6.9

Non-cash interest, net

381

0.1

381

0.2

286

0.1

1,449

0.1

1,146

0.2

Acquisition and integration related costs

3,378

1.3

1,321

0.5

1,965

1.0

7,576

0.8

18,784

2.6

Loss on debt extinguishment

—

—

—

—

—

—

193,098

20.0

—

—

Gain on acquired assets

(10,084

)

(3.9

)

—

—

—

—

(10,084

)

(1.0

)

—

—

Tax effect of non-GAAP adjustments

8,574

3.3

5,436

2.2

1,422

0.7

17,039

1.8

8,845

1.2

Adjusted net income (Non-GAAP)

$

71,386

27.3

$

68,207

27.1

$

54,245

27.0

$

263,372

27.2

$

188,217

25.8

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Net income

Income per diluted share

Net income

Income per diluted share

Net income

Income per diluted share

Net income (loss)

Income (loss) per diluted share

Net income

Income per diluted share

Net income (loss) - GAAP diluted

$

45,120

$

0.59

$

36,534

$

0.48

$

29,414

$

0.39

$

(54,210

)

$

(0.73

)

$

76,859

$

1.04

Adjusted net income (Non-GAAP)

$

71,386

$

0.94

$

68,207

$

0.90

$

54,245

$

0.73

$

263,372

$

3.47

$

188,217

$

2.56

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Shares

Shares

Shares

Shares

Shares

Diluted shares - GAAP

76,252

75,864

74,524

73,986

73,575

Incremental shares

—

—

—

1,873

—

Adjusted diluted shares (Non-GAAP)

76,252

75,864

74,524

75,859

73,575

Three Months Ended

Twelve Months Ended

October 3, 2025

July 4, 2025

September 27, 2024

October 3, 2025

September 27, 2024

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Amount

% Revenue

Interest income - GAAP

$

8,016

3.1

$

7,598

3.0

$

6,244

3.1

$

29,853

3.1

$

22,986

3.2

Interest expense - GAAP

(1,793

)

(0.7

)

(1,178

)

(0.5

)

(1,274

)

(0.6

)

(5,516

)

(0.6

)

(5,136

)

(0.7

)

Non-cash interest expense

381

0.1

381

0.2

286

0.1

1,449

0.1

1,146

0.2

Adjusted interest income (Non-GAAP)

$

6,604

2.5

$

6,801

2.7

$

5,256

2.6

$

25,786

2.7

$

18,996

2.6